6.06

1.00% 0.06

Pre-market: 5.51 -0.55 -9.08%

Precipio Inc (PRPO)

Overview News Price History Financials Discussions Forecast Stock Split

Precipio Inc stock is traded at $6.06, with a volume of 26,152. It is up +1.00% in the last 24 hours and up +4.10% over the past month. Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Previous Close:

$6.00

Open:

$6.025

24h Volume:

26,152

Relative Volume:

3.59

Market Cap:

$8.98M

Revenue:

$15.81M

Net Income/Loss:

$-4.90M

P/E Ratio:

-1.7719

EPS:

-3.42

Net Cash Flow:

$-2.65M

1W Performance:

-2.26%

1M Performance:

+4.10%

6M Performance:

+29.21%

1Y Performance:

+13.27%

1-Day Range:

$6.025

$6.34

1-Week Range:

$5.71

$6.3949

52-Week Range:

$4.31

$7.30

Precipio Inc Stock (PRPO) Company Profile

Name

Precipio Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (58)

Phone

203 787 7888

Address

12325 EMMET ST, OMAHA, CT

Employee

Twitter

@precipiodx

Next Earnings Date

2024-11-11

Latest SEC Filings

PRPO's Discussions on Twitter

Compare PRPO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPO Precipio Inc	6.06	8.98M	15.81M	-4.90M	-2.65M	-3.42
TMO Thermo Fisher Scientific Inc	556.99	213.05B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	237.62	171.63B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	143.43	40.54B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	197.96	35.93B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	418.63	34.28B	3.84B	866.24M	792.60M	10.37

Precipio Inc Stock (PRPO) Latest News

Jan 09, 2025

(PRPO) Trading Report - Stock Traders Daily

Jan 09, 2025

Dec 30, 2024

(PRPO) Trading Advice - Stock Traders Daily

Dec 30, 2024

Dec 20, 2024

Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues - Simply Wall St

Dec 20, 2024

Dec 19, 2024

PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

How to Take Advantage of moves in (PRPO) - Stock Traders Daily

Nov 28, 2024

PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

Nov 25, 2024

PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com

Nov 25, 2024

PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

Two Smaller Companies Worthy of Your "Attention" - Yahoo Finance

Nov 25, 2024

PRPO (Precipio) 3-Year FCF Growth Rate : 32.40% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 23, 2024

PRPO (Precipio) GF Value Rank : 2 (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024

PRPO (Precipio) Debt-to-Equity : 0.11 (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Nov 20, 2024